A mesoporous, silica‐supported, chiral iridium catalyst with a highly ordered dimensional‐hexagonal mesostructure was prepared by postgrafting the organometallic complex (1‐diphenylphosphino‐2‐triethylsilylethane)[( R,R )‐1,2‐diphenylethylenediamine]iridium chloride {IrCl[PPh 2 (CH 2 ) 2 Si(OEt) 3 ] 2 [( R , R )‐DPEN] (DPEN=1,2‐diphenylethylenediamine)} on SBA‐15 silica. During the asymmetric hydrogenation of various aromatic ketones under 40 atm of hydrogen, the mesoporous, silica‐supported, chiral iridium catalyst exhibited high catalytic activity (more than 95% conversions) and excellent enantioselectivity (up to more than 99% ee ). The catalyst could be recovered easily and used repetitively seven times without significantly affecting the catalytic activity and the enantioselectivity.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: